Image Source: AsiaOne
Hua Medicine Selected for Inclusion in the MSCI Hong Kong Micro Cap IndexGlobeNewswireJune 01, 2020SHANGHAI, China, May 31, 2020 (GLOBE NEWSWIRE) -- Hua Medicine (the “Company”, Stock Code: 2552. HK), a leading innovative drug development company focused on developing novel therapies for the treatment of diabetes, is pleased to announce that the Company has been officially included as a constituent stock of the MSCI Hong Kong Micro Cap Index. The relevant change has been implemented as of the close of May 29, 2020.
Source: AsiaOne